Rivaroxaban Not Superior to Aspirin for Recurrent Stroke After ESUS Rivaroxaban Not Superior to Aspirin for Recurrent Stroke After ESUS

Researchers were ' surprised and disappointed ' to report rivaroxaban did not prevent recurrent stroke after first embolic stroke of undetermined source better than did aspirin but rather increased major bleeding.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news